Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study

CONCLUSION: This population-based study provides evidence that bivalent COVID-19 mRNA vaccination is not associated with risk of myocarditis/pericarditis. These findings provide important insights into the safety profile of bivalent COVID-19 mRNA vaccines and support their continued use as updated boosters.PMID:38615382 | DOI:10.1016/j.intimp.2024.112022

Source: International Immunopharmacology - April 14, 2024 Category: Allergy & Immunology Authors: Congqin Chen Chunmei Chen Longxing Cao Jie Fang Jie Xiao Source Type: research